DBV Technologies SA (DBVT)
0.4881
-0.02
(-3.92%)
USD |
NASDAQ |
Nov 21, 16:00
0.4801
-0.01
(-1.64%)
After-Hours: 20:00
DBV Technologies Net Income (Quarterly): -30.44M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -30.44M |
| June 30, 2024 | -33.12M |
| March 31, 2024 | -27.34M |
| December 31, 2023 | -11.19M |
| September 30, 2023 | -16.74M |
| June 30, 2023 | -24.24M |
| March 31, 2023 | -20.56M |
| December 31, 2022 | -39.24M |
| September 30, 2022 | -17.29M |
| June 30, 2022 | -23.04M |
| March 31, 2022 | -16.71M |
| December 31, 2021 | -13.67M |
| Date | Value |
|---|---|
| September 30, 2021 | -24.03M |
| June 30, 2021 | -30.65M |
| March 31, 2021 | -29.45M |
| December 31, 2020 | -39.48M |
| September 30, 2020 | -30.96M |
| June 30, 2020 | -48.20M |
| March 31, 2020 | -40.91M |
| December 31, 2019 | -50.28M |
| September 30, 2019 | -30.99M |
| December 31, 2018 | -55.60M |
| September 30, 2018 | -51.04M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-50.28M
Minimum
Dec 2019
-11.19M
Maximum
Dec 2023
-28.38M
Average
-28.40M
Median
Net Income (Quarterly) Benchmarks
| Edap TMS SA | -7.038M |
| Cellectis SA | -23.06M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -17.62M |
| Akari Therapeutics PLC | -2.895M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 30.33M |
| EPS Diluted (Quarterly) | -0.32 |
| Enterprise Value | 1.221M |
| Earnings Yield | -215.1% |